| Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000) LB Silverman, KE Stevenson, JE O'Brien, BL Asselin, RD Barr, L Clavell, ... Leukemia 24 (2), 320-334, 2010 | 358 | 2010 |
| Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a … AE Place, KE Stevenson, LM Vrooman, MH Harris, SK Hunt, JE O'Brien, ... The lancet oncology 16 (16), 1677-1690, 2015 | 228 | 2015 |
| Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity RA Drachtman, PD Cole, CB Golden, SJ James, S Melnyk, J Aisner, ... Pediatric hematology and oncology 19 (5), 319-327, 2002 | 143 | 2002 |
| The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber … LM Vrooman, DS Neuberg, KE Stevenson, BL Asselin, UH Athale, ... European journal of cancer 47 (9), 1373-1379, 2011 | 138 | 2011 |
| Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia LB Silverman, JG Supko, KE Stevenson, C Woodward, LM Vrooman, ... Blood, The Journal of the American Society of Hematology 115 (7), 1351-1353, 2010 | 136 | 2010 |
| Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model JB Wollack, B Makori, S Ahlawat, R Koneru, SC Picinich, A Smith, ... Journal of neurochemistry 104 (6), 1494-1503, 2008 | 111 | 2008 |
| Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia PD Cole, BA Kamen Mental retardation and developmental disabilities research reviews 12 (3 …, 2006 | 105 | 2006 |
| Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation MA Perales, I Ceberio, P Armand, LJ Burns, R Chen, PD Cole, AM Evens, ... Biology of Blood and Marrow Transplantation 21 (6), 971-983, 2015 | 97 | 2015 |
| Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001 LM Vrooman, TM Blonquist, MH Harris, KE Stevenson, AE Place, SK Hunt, ... Blood advances 2 (12), 1449-1458, 2018 | 93 | 2018 |
| Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre … PD Cole, KM McCarten, Q Pei, M Spira, ML Metzger, RA Drachtman, ... The Lancet Oncology 19 (9), 1229-1238, 2018 | 83 | 2018 |
| Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an … V Vijayanathan, M Gulinello, N Ali, PD Cole Behavioural brain research 225 (2), 491-497, 2011 | 76 | 2011 |
| Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report PD Cole, CL Schwartz, RA Drachtman, PA De Alarcon, L Chen, ... Journal of Clinical Oncology 27 (9), 1456, 2009 | 76 | 2009 |
| Polymorphisms in genes related to oxidative stress are associated with inferior cognitive function after therapy for childhood acute lymphoblastic leukemia PD Cole, Y Finkelstein, KE Stevenson, TM Blonquist, V Vijayanathan, ... Journal of Clinical Oncology 33 (19), 2205, 2015 | 73 | 2015 |
| Effects of overexpression of γ-glutamyl hydrolase on methotrexate metabolism and resistance PD Cole, BA Kamen, R Gorlick, D Banerjee, AK Smith, E Magill, ... Cancer research 61 (11), 4599-4604, 2001 | 73 | 2001 |
| Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma KM Kelly, D Hodgson, B Appel, L Chen, PD Cole, T Horton, FG Keller, ... Pediatric blood & cancer 60 (6), 972-978, 2013 | 69 | 2013 |
| Successful treatment of human herpesvirus 6 encephalitis in a bone marrow transplant recipient PD Cole, J Stiles, F Boulad, TN Small, RJ O'Reilly, D George, P Szabolcs, ... Clinical infectious diseases 27 (3), 653-654, 1998 | 66 | 1998 |
| Systemic methotrexate induces spatial memory deficits and depletes cerebrospinal fluid folate in rats Y Li, V Vijayanathan, ME Gulinello, PD Cole Pharmacology Biochemistry and Behavior 94 (3), 454-463, 2010 | 60 | 2010 |
| High‐dose methotrexate in acute lymphoblastic leukemia: where is the evidence for its continued use? E Mantadakis, PD Cole, BA Kamen Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25 (5 …, 2005 | 59 | 2005 |
| ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients ADJ Pearson, C Rossig, G Lesa, SJ Diede, S Weiner, J Anderson, J Gray, ... European Journal of Cancer 127, 52-66, 2020 | 57 | 2020 |
| Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group KM Kelly, PD Cole, Q Pei, R Bush, KB Roberts, DC Hodgson, ... British journal of haematology 187 (1), 39-48, 2019 | 55 | 2019 |
Kristen StevensonStatistician, Dana-Farber Cancer InstituteVerified email at ds.dfci.harvard.edu
